Scarica l'app Stockscreener
101.69
2.37%
2.345
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$99.35
Aprire:
$99.65
Volume 24 ore:
5.10M
Relative Volume:
0.75
Capitalizzazione di mercato:
$130.45B
Reddito:
$34.76B
Utile/perdita netta:
$4.79B
Rapporto P/E:
27.45
EPS:
3.7049
Flusso di cassa netto:
$5.21B
1 W Prestazione:
+6.08%
1M Prestazione:
+6.13%
6M Prestazione:
+20.48%
1 anno Prestazione:
+20.01%
Intervallo 1D:
$99.26
$101.77
Intervallo di 1 settimana:
$95.80
$102.59
Portata 52W:
$79.29
$102.59
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
101.70 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
ABT
Abbott Laboratories
|
128.45 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
369.30 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
EW
Edwards Lifesciences Corp
|
84.99 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Medtronic (NYSE:MDT) Price Target Raised to $110.00 - MarketBeat
FY2026 EPS Estimates for Medtronic Increased by Analyst - MarketBeat
Q3 Earnings Estimate for Medtronic Issued By Leerink Partnrs - MarketBeat
Howe & Rusling Inc. Acquires Shares of 61,156 Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Primecap Management Co. CA - MarketBeat
TD Waterhouse Canada Inc. Purchases 3,902 Shares of Medtronic PLC $MDT - MarketBeat
The Goldman Sachs Group Upgrades Medtronic (NYSE:MDT) to "Neutral" - MarketBeat
Medtronic PLC $MDT Stake Trimmed by Ensign Peak Advisors Inc - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Cuts Stake in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Archer Investment Corp - MarketBeat
ABN AMRO Bank N.V. Purchases New Shares in Medtronic PLC $MDT - MarketBeat
Medtronic promotes from within for its new CTO - MassDevice
Barclays Raises Medtronic (MDT) Price Target, Maintains Overweig - GuruFocus
Medtronic (MDT) Analyst Rating Update: Price Target Raised to $1 - GuruFocus
Medtronic Spark Scholarship Launches To Help Students From Low-Income Households Globally Pursue Health Tech Careers - ACCESS Newswire
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers - FinancialContent
Internal Neuromodulation Devices Market Poised to Exceed USD 44.57 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.
Wells Fargo & Company Boosts Medtronic (NYSE:MDT) Price Target to $114.00 - MarketBeat
Truist Securities raises Medtronic stock price target to $110 on PFA strength - Investing.com UK
Medtronic (NYSE:MDT) Given New $109.00 Price Target at Robert W. Baird - MarketBeat
Is Medtronic plc (2M6) stock trading at attractive multiplesQuarterly Portfolio Report & Precise Entry and Exit Recommendations - newser.com
Artisan Partners Limited Partnership Has $104.89 Million Stake in Medtronic PLC $MDT - MarketBeat
Medtronic plc (NYSE:MDT) S&P Futures Track MedTech Expansion - Kalkine Media
Baird Maintains Medtronic (MDT) Neutral Recommendation - Nasdaq
Why Medtronic plc. Ordinary Shares stock signals breakout potential2025 Technical Overview & Fast Momentum Entry Tips - newser.com
These Analysts Increase Their Forecasts On Medtronic After Strong Q2 Earnings - Benzinga
Morgan Stanley Raises Medtronic (MDT) Price Target to $117 | MDT Stock News - GuruFocus
Goldman Sachs Upgrades Medtronic (MDT) Following Strong Q2 Resul - GuruFocus
Medtronic Target of Unusually High Options Trading (NYSE:MDT) - MarketBeat
Truist Adjusts Price Target on Medtronic to $110 From $103, Maintains Hold Rating - MarketScreener
RBC Capital Raises Price Target for Medtronic (MDT) on November 19 | MDT Stock News - GuruFocus
Medtronic upgraded at Goldman Sachs after guidance raise - MSN
Medtronic stock upgraded at Goldman Sachs (MDT:NYSE) - Seeking Alpha
VP Smith Files To Sell 30,000 Of Medtronic PLC [MDT] - TradingView
[144] Medtronic plc SEC Filing - Stock Titan
UBS Adjusts Price Target on Medtronic to $102 From $95, Maintains Neutral Rating - MarketScreener
Medtronic's Q2 Beat Rekindles Growth Story — But Analysts Say It's Not Enough Yet - Benzinga
Medtronic (NYSE:MDT) Sets New 12-Month High Following Strong Earnings - MarketBeat
Barclays Adjusts Price Target on Medtronic to $111 From $109, Maintains Overweight Rating - MarketScreener
Medtronic plc (NYSE:MDT) Q2 2026 Earnings Call Transcript - MSN
Medtronic (NYSE:MDT) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
MDT: Baird Raises Price Target for Medtronic to $109 | MDT Stock News - GuruFocus
Vanguard Group Inc. Grows Stock Holdings in Medtronic PLC $MDT - MarketBeat
Here Are Wednesday's Top Wall Street Analyst Research Calls: DoorDash, Freeport-McMoRan, GitLab, Home Depot, Medtronic, Molson-Coors, and More - 24/7 Wall St.
Will Medtronic plc. Ordinary Shares stock rise with strong economy2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Rothschild & Co Redburn Adjusts Price Target on Medtronic to $111 From $101, Maintains Buy Rating - MarketScreener
RBC Raises Price Target on Medtronic to $118 From $111, Keeps Outperform Rating - MarketScreener
Will Medtronic plc (2M6) stock benefit from sector leadershipShort Setup & Real-Time Volume Analysis Alerts - newser.com
Medtronic (NYSE:MDT) Updates FY 2026 Earnings Guidance - MarketBeat
Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum - MarketBeat
Medtronic PLC $MDT Shares Bought by Raiffeisen Bank International AG - MarketBeat
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):